CEO, Feldan Therapeutics
Delivery to CNS
Not only did François-Thomas Michaud manage to launch an innovative new biotech company, Feldan Therapeutics, but he did so while still enrolled in university.
This Quebec company developed a unique technology that enables the introduction of proteins into cells in order to effect modifications and train them to, for example, kill cancer cells.
Nearly 10 years after its beginnings, this small business now stands alongside some of the biggest in the industry. For the past several months, the company has been collaborating with a large U.S. biopharmaceutical firm in order to develop a procedure for inserting antibodies into cells.